 | • レポートコード：D005-09816 • 出版社/出版日：GlobalInfoResearch / 2020年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ライム病ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。ライム病ワクチンの種類別市場規模（不活化ワクチン、弱毒ワクチン）、用途別市場規模（病院、科学研究、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Merck、Merial、Zoetis ・地域別グローバル市場分析 2015年-2020年 ・ライム病ワクチンの北米市場（アメリカ、カナダ、メキシコ） ・ライム病ワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ライム病ワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ライム病ワクチンの南米市場（ブラジル、アルゼンチン） ・ライム病ワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：不活化ワクチン、弱毒ワクチン ・用途別分析：病院、科学研究、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Lyme Disease Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Lyme Disease Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Lyme Disease Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Lyme Disease Vaccine market has been segmented into
Inactivated Vaccine
Attenuated Vaccine
By Application, Lyme Disease Vaccine has been segmented into:
Hospital
Scientific Research
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Lyme Disease Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Lyme Disease Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Lyme Disease Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Lyme Disease Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Lyme Disease Vaccine Market Share Analysis
Lyme Disease Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Lyme Disease Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Lyme Disease Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Lyme Disease Vaccine are:
Merck
Merial
Zoetis
Among other players domestic and global, Lyme Disease Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lyme Disease Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Lyme Disease Vaccine, with price, sales, revenue and global market share of Lyme Disease Vaccine in 2018 and 2019.
Chapter 3, the Lyme Disease Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lyme Disease Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Lyme Disease Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Lyme Disease Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Lyme Disease Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Lyme Disease Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Inactivated Vaccine
1.2.3 Attenuated Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Lyme Disease Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Scientific Research
1.3.4 Others
1.4 Overview of Global Lyme Disease Vaccine Market
1.4.1 Global Lyme Disease Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Lyme Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merial
2.2.1 Merial Details
2.2.2 Merial Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Merial SWOT Analysis
2.2.4 Merial Product and Services
2.2.5 Merial Lyme Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Zoetis
2.3.1 Zoetis Details
2.3.2 Zoetis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Zoetis SWOT Analysis
2.3.4 Zoetis Product and Services
2.3.5 Zoetis Lyme Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Lyme Disease Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Lyme Disease Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Lyme Disease Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Lyme Disease Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Lyme Disease Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Lyme Disease Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Lyme Disease Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Lyme Disease Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Lyme Disease Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Lyme Disease Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Lyme Disease Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Lyme Disease Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Lyme Disease Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Lyme Disease Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Lyme Disease Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Lyme Disease Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Lyme Disease Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Lyme Disease Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Lyme Disease Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Lyme Disease Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Lyme Disease Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Lyme Disease Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Lyme Disease Vaccine Sales and Growth Rate (2015-2020)
6.4 France Lyme Disease Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Lyme Disease Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Lyme Disease Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Lyme Disease Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Lyme Disease Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Lyme Disease Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Lyme Disease Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Lyme Disease Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Lyme Disease Vaccine Sales and Growth Rate (2015-2020)
7.5 India Lyme Disease Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Lyme Disease Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Lyme Disease Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Lyme Disease Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Lyme Disease Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Lyme Disease Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Lyme Disease Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Lyme Disease Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Lyme Disease Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Lyme Disease Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Lyme Disease Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Lyme Disease Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Lyme Disease Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Lyme Disease Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Lyme Disease Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Lyme Disease Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Lyme Disease Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Lyme Disease Vaccine Price by Type (2015-2020)
11 Global Lyme Disease Vaccine Market Segment by Application
11.1 Global Lyme Disease Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Lyme Disease Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Lyme Disease Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Lyme Disease Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Lyme Disease Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Lyme Disease Vaccine Market Forecast (2021-2025)
12.2.2 Europe Lyme Disease Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Lyme Disease Vaccine Market Forecast (2021-2025)
12.2.4 South America Lyme Disease Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Lyme Disease Vaccine Market Forecast (2021-2025)
12.3 Lyme Disease Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Lyme Disease Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Lyme Disease Vaccine Market Share Forecast by Type (2021-2025)
12.4 Lyme Disease Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Lyme Disease Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Lyme Disease Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Lyme Disease Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Lyme Disease Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Lyme Disease Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Lyme Disease Vaccine Major Business
Table 9. Merck Lyme Disease Vaccine Total Revenue (USD Million) (2018-2019)
Table 10. Merck SWOT Analysis
Table 11. Merck Lyme Disease Vaccine Product and Services
Table 12. Merck Lyme Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Merial Basic Information, Manufacturing Base and Competitors
Table 14. Merial Lyme Disease Vaccine Major Business
Table 15. Merial Lyme Disease Vaccine Total Revenue (USD Million) (2018-2019)
Table 16. Merial SWOT Analysis
Table 17. Merial Lyme Disease Vaccine Product and Services
Table 18. Merial Lyme Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Zoetis Basic Information, Manufacturing Base and Competitors
Table 20. Zoetis Lyme Disease Vaccine Major Business
Table 21. Zoetis Lyme Disease Vaccine Total Revenue (USD Million) (2018-2019)
Table 22. Zoetis SWOT Analysis
Table 23. Zoetis Lyme Disease Vaccine Product and Services
Table 24. Zoetis Lyme Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Global Lyme Disease Vaccine Sales by Manufacturer (2018-2019) (K Units)
Table 26. Global Lyme Disease Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 27. Global Lyme Disease Vaccine Sales by Regions (2015-2020) (K Units)
Table 28. Global Lyme Disease Vaccine Sales Market Share by Regions (2015-2020)
Table 29. Global Lyme Disease Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 30. North America Lyme Disease Vaccine Sales by Countries (2015-2020) (K Units)
Table 31. North America Lyme Disease Vaccine Sales Market Share by Countries (2015-2020)
Table 32. North America Lyme Disease Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 33. North America Lyme Disease Vaccine Revenue Market Share by Countries (2015-2020)
Table 34. Europe Lyme Disease Vaccine Sales by Countries (2015-2020) (K Units)
Table 35. Europe Lyme Disease Vaccine Sales Market Share by Countries (2015-2020)
Table 36. Europe Lyme Disease Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 37. Asia-Pacific Lyme Disease Vaccine Sales by Regions (2015-2020) (K Units)
Table 38. Asia-Pacific Lyme Disease Vaccine Sales Market Share by Regions (2015-2020)
Table 39. Asia-Pacific Lyme Disease Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 40. South America Lyme Disease Vaccine Sales by Countries (2015-2020) (K Units)
Table 41. South America Lyme Disease Vaccine Sales Market Share by Countries (2015-2020)
Table 42. South America Lyme Disease Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 43. South America Lyme Disease Vaccine Revenue Market Share by Countries (2015-2020)
Table 44. Middle East & Africa Lyme Disease Vaccine Sales by Countries (2015-2020) (K Units)
Table 45. Middle East & Africa Lyme Disease Vaccine Sales Market Share by Countries (2015-2020)
Table 46. Middle East & Africa Lyme Disease Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 47. Middle East & Africa Lyme Disease Vaccine Revenue Market Share by Countries (2015-2020)
Table 48. Global Lyme Disease Vaccine Sales by Type (2015-2020) (K Units)
Table 49. Global Lyme Disease Vaccine Sales Share by Type (2015-2020)
Table 50. Global Lyme Disease Vaccine Revenue by Type (2015-2020) (USD Million)
Table 51. Global Lyme Disease Vaccine Revenue Share by Type (2015-2020)
Table 52. Global Lyme Disease Vaccine Sales by Application (2015-2020) (K Units)
Table 53. Global Lyme Disease Vaccine Sales Share by Application (2015-2020)
Table 54. Global Lyme Disease Vaccine Sales Forecast by Regions (2021-2025) (K Units)
Table 55. Global Lyme Disease Vaccine Market Share Forecast by Regions (2021-2025)
Table 56. Global Lyme Disease Vaccine Sales Forecast by Type (2021-2025) (K Units)
Table 57. Global Lyme Disease Vaccine Market Share Forecast by Type (2021-2025)
Table 58. Global Lyme Disease Vaccine Sales Forecast by Application (2021-2025)
Table 59. Global Lyme Disease Vaccine Market Share Forecast by Application (2021-2025)
Table 60. Direct Channel Pros & Cons
Table 61. Indirect Channel Pros & Cons
Table 62. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Lyme Disease Vaccine Picture
Figure 2. Global Sales Market Share of Lyme Disease Vaccine by Type in 2019
Figure 3. Inactivated Vaccine Picture
Figure 4. Attenuated Vaccine Picture
Figure 5. Lyme Disease Vaccine Sales Market Share by Application in 2018
Figure 6. Hospital Picture
Figure 7. Scientific Research Picture
Figure 8. Others Picture
Figure 9. Global Lyme Disease Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Lyme Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Lyme Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Lyme Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Lyme Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Lyme Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Lyme Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Lyme Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Lyme Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Lyme Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Lyme Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Lyme Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Lyme Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Lyme Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Lyme Disease Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Lyme Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Lyme Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Lyme Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Lyme Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Lyme Disease Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Lyme Disease Vaccine Sales Market Share by Manufacturer in 2019
Figure 30. Global Lyme Disease Vaccine Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Lyme Disease Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Lyme Disease Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Lyme Disease Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Lyme Disease Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Lyme Disease Vaccine Revenue Market Share by Regions (2015-2020)
Figure 37. Global Lyme Disease Vaccine Revenue Market Share by Regions in 2018
Figure 38. North America Lyme Disease Vaccine Sales and Growth Rate (2015-2020)
Figure 39. Europe Lyme Disease Vaccine Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Lyme Disease Vaccine Sales and Growth Rate (2015-2020)
Figure 41. South America Lyme Disease Vaccine Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Lyme Disease Vaccine Sales and Growth Rate (2015-2020)
Figure 43. North America Lyme Disease Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Lyme Disease Vaccine Sales Market Share by Countries (2015-2020)
Figure 45. North America Lyme Disease Vaccine Sales Market Share by Countries in 2018
Figure 46. North America Lyme Disease Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Lyme Disease Vaccine Revenue Market Share by Countries in 2018
Figure 48. United States Lyme Disease Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Lyme Disease Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Lyme Disease Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Lyme Disease Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Lyme Disease Vaccine Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Lyme Disease Vaccine Revenue Market Share by Countries in 2019
Figure 54. Germany Lyme Disease Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Lyme Disease Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Lyme Disease Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Lyme Disease Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Lyme Disease Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Lyme Disease Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Lyme Disease Vaccine Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Lyme Disease Vaccine Revenue Market Share by Regions 2019
Figure 62. China Lyme Disease Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Lyme Disease Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Lyme Disease Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Lyme Disease Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Lyme Disease Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Lyme Disease Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Lyme Disease Vaccine Sales Market Share by Countries in 2019
Figure 69. South America Lyme Disease Vaccine Revenue Market Share by Countries in 2019
Figure 70. Brazil Lyme Disease Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Lyme Disease Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Lyme Disease Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Lyme Disease Vaccine Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Lyme Disease Vaccine Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Lyme Disease Vaccine Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Lyme Disease Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Lyme Disease Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Lyme Disease Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Lyme Disease Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Lyme Disease Vaccine Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Lyme Disease Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Lyme Disease Vaccine Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Lyme Disease Vaccine Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Lyme Disease Vaccine Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Lyme Disease Vaccine Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Lyme Disease Vaccine Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
病気管理＆予防ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Disease Control and Prevention Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.6% in the forecast period of 2020 to 2025 and will expected to reach USD 55270 million by 2025, from USD 42850 million in 2019. The…- 口蹄疫（FMD）ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Foot and Mouth Disease (FMD) Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 9.2% in the forecast period of 2020 to 2025 and will expected to reach USD 1280.5 million by 2025, from USD 900.9 million in 2019. The …
- ニューカッスル病ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global Newcastle Disease Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.3% in the forecast period of 2020 to 2025 and will expected to reach USD 348.3 million by 2025, from USD 305.3 million in 2019. The Newc…
- 麻疹ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Measle Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Measle Vaccine market report p…
- mRNAワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global mRNA Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The mRNA Vaccine market report provi…